Saul A. Rosenberg
Affiliations: | Medicine/Oncology | Stanford University Medical School |
Google:
"Saul Rosenberg"Parents
Sign in to add mentor| Hymer Friedell | research assistant | 1947 | Atomic Energy Research Lab | |
| (Pre-doctoral research) | ||||
| Lloyd F. Craver | post-doc | 1959 | Memorial Sloan Kettering Cancer | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mou E, Advani RH, von Eyben R, et al. (2021) Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies). International Journal of Radiation Oncology, Biology, Physics. 110: 444-451 |
| Weil CR, Qian Y, Von Eyben R, et al. (2020) Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation. Leukemia & Lymphoma. 61: 2428-2434 |
| Moding EJ, Advani R, Rosenberg SA, et al. (2018) Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 129: 507-512 |
| Lynch RC, Sundaram V, Desai M, et al. (2018) No Utility of Routine Laboratory Testing during Surveillance in Detecting Relapse in Patients with Classic Hodgkin Lymphoma in First Remission Blood. 132: 615-615 |
| Moding E, Advani R, Rosenberg S, et al. (2018) Prognostic Factors and Patterns of Failure in Advanced Stage Hodgkin Lymphoma Treated with Stanford V and Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 102: S189-S190 |
| Weil C, Qian Y, Von Eyben R, et al. (2018) The Outcomes of Patients with Unfavorable Stage I-II Classic Hodgkin Lymphoma Treated with Stanford V Chemotherapy and Limited Irradiation International Journal of Radiation Oncology*Biology*Physics. 102: S189 |
| Hoppe RT, Rosenberg SA. (2015) The Paris conference "La Radiothérapie de la Maladie de Hodgkin": a first step in the cure of Hodgkin disease. International Journal of Radiation Oncology, Biology, Physics. 92: 3-4 |
| Tan D, Horning SJ, Hoppe RT, et al. (2013) Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood. 122: 981-7 |
| Koontz MZ, Horning SJ, Balise R, et al. (2013) Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 592-8 |
| Advani RH, Hoppe RT, Baer D, et al. (2013) Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 1044-8 |